Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib Maintenance in c-kit+ Extensive-Stage SCLC
NCT00248482Phase 2Completed
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- Feb 2002
- Primary completion
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in small cell lung cancer (SCLC), sponsored by Barbara Ann Karmanos Cancer Institute. Started Feb 2002; status: completed.
02
Drugs
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00248482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00248482.